FINWIRES · TerminalLIVE
FINWIRES

Barclays Downgrades QIAGEN to Equalweight From Overweight, Adjusts Price Target to $44 From $48

-- QIAGEN (QGEN) has an average rating of overweight and mean price target of $54.01, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

相關文章